期刊
ANALYTICAL AND BIOANALYTICAL CHEMISTRY
卷 403, 期 6, 页码 1651-1660出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00216-012-5982-y
关键词
Metabonomics; Aortic abdominal aneurysm; Metabolic pathways
资金
- EC, FAD [FP-7, HEALTH F2-2008-200647]
- Spanish MICINN [SAF2010/21852, CTQ2011-23562]
- CAM [S2006/GEN-0247]
- Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III [Red RECAVA (RD06/0014/0035), EUS2008-03565]
- Fundacion Pro CNIC
Abdominal aortic aneurysm (AAA) is an important health problem, both because of AAA rupture and death and because of increased cardiovascular mortality. Identification of new biomarkers of AAA may suggest novel pathological mechanisms and targets for new medical treatments to slow AAA progression. Metabolic changes in AAA patients were mainly related to carbohydrate and lipid metabolism and many of these changes can be associated with a situation of insulin resistance (which can be related to metabolic syndrome) together with altered amino acid metabolism. For the first time, metabolites that can be associated with differential metabolism by the gut microflora of AAA patients have also been found. Moreover, aminomalonic acid in plasma has been shown to be the metabolite with the biggest difference between patients suffering from large aneurysm (> 5 cm) and controls.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据